Related Experiment Video
Updated: Jul 4, 2026

Site-Specific Lysine Lactylation via Genetic Code Expansion in E. coli and Mammalian Cells
Published on: February 24, 2026
Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73
Masahiro Kawahara1, Toshiyuki Hori, Kazuhisa Chonabayashi
1Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Abstract:
Down-regulation of the Kpm/Lats2 tumor suppressor is observed in various malignancies and associated with poor prognosis in acute lymphoblastic leukemia. We documented that Kpm/Lats2 was markedly decreased in several leukemias that were highly resistant to conventional chemotherapy. Silencing of Kpm/Lats2 expression in leukemic cells did not change the rate of cell growth but rendered the cells more resistant to DNA damage-inducing agents. Expression of p21 and PUMA was strongly induced by these agents in control cells, despite defective p53, but was only slightly induced in Kpm/Lats2-knockdown cells. DNA damage-induced nuclear accumulation of p73 was clearly observed in control cells but hardly detected in Kpm/Lats2-knockdown cells. Chromatin immunoprecipitation (ChIP) assay showed that p73 was recruited to the PUMA gene promoter in control cells but not in Kpm/Lats2-knockdown cells after DNA damage. The analyses with transient coexpression of Kpm/Lats2, YAP2, and p73 showed that Kpm/Lats2 contributed the stability of YAP2 and p73, which was dependent on the kinase function of Kpm/Lats2 and YAP2 phosphorylation at serine 127. Our results suggest that Kpm/Lats2 is involved in the fate of p73 through the phosphorylation of YAP2 by Kpm/Lats2 and the induction of p73 target genes that underlie chemosensitivity of leukemic cells.
Insights
The Kpm/Lats2 tumor suppressor is crucial for leukemia chemotherapy sensitivity. Its down-regulation increases resistance by impairing p73 target gene induction, impacting DNA damage response.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Kpm/Lats2 tumor suppressor is downregulated in malignancies, correlating with poor prognosis in acute lymphoblastic leukemia.
- Kpm/Lats2 is decreased in chemotherapy-resistant leukemias.
Purpose of the Study:
- To investigate the role of Kpm/Lats2 in leukemia chemoresistance.
- To elucidate the mechanism by which Kpm/Lats2 influences the DNA damage response and chemosensitivity.
Main Methods:
- Kpm/Lats2 expression was silenced in leukemic cells.
- Cells were treated with DNA damage-inducing agents.
- Expression of p21, PUMA, and p73 was analyzed.
- Chromatin immunoprecipitation (ChIP) assays were performed.
- Transient coexpression analyses were conducted.
Main Results:
- Kpm/Lats2 silencing increased chemoresistance without affecting cell growth.
- DNA damage-induced p21 and PUMA expression was impaired in Kpm/Lats2-knockdown cells.
- Nuclear accumulation and PUMA promoter recruitment of p73 were reduced upon Kpm/Lats2 knockdown.
- Kpm/Lats2 stabilizes YAP2 and p73, dependent on its kinase activity and YAP2 phosphorylation.
Conclusions:
- Kpm/Lats2 is involved in regulating p73 stability and function.
- Kpm/Lats2 promotes chemosensitivity in leukemic cells by inducing p73 target genes via YAP2 phosphorylation.
- Kpm/Lats2 represents a potential therapeutic target for overcoming chemoresistance in leukemia.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
09:09Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
Published on: November 10, 2017
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle